Six Companies Warned by FDA for Selling Lidocaine-Laced Topical Pain-Relief Products

FDA cautions that widely used pain-relief creams could present serious health hazards

The FDA has issued a warning to six companies for selling unapproved and misbranded topical pain-relief products with excessive lidocaine content. These products pose serious risks to consumers, especially when used on large areas of skin or irritated skin. Jill Furman, director of the Office of Compliance in the FDA’s Center for Drug Evaluation and Research, emphasized the importance of avoiding these products to prevent adverse effects such as irregular heartbeat, seizures, and breathing difficulties.

To avoid these risks, the FDA recommends avoiding products containing more than 4% lidocaine and refraining from using them on large areas of skin. The FDA also advises against wrapping the product with dressings or plastic wraps. Some of the products cited by the FDA include TKTX Numb Maximum Strength Pain Reliever, NumbSkin Lidocaine Numbing Creams, and Signature Tattoo Numbing Cream.

Individuals interested in learning more about the specific products mentioned in the warning can refer to the FDA’s official press release. It is crucial to take heed of these warnings while undergoing cosmetic procedures to protect your health and well-being.

Leave a Reply